Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine

Vaccine

Volumn 24, Issue 37-39, 2006, Pages 6175-6186

  Schleiss, Mark R ^a   Stroup, Greg ^b   Pogorzelski, Kelly ^c   McGregor, Alistair ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Meridian Bioscience   (United States)

^c CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Animal models of CMV infection; Bacterial artificial chromsomes; Congenital CMV infection; Cytomegalovirus (CMV) vaccines; DNA cytomegalovirus (CMV) vaccines; DNA vaccines; Placenta; TORCH infection

Indexed keywords

ADJUVANT; CYTOMEGALOVIRUS VACCINE; DNA VACCINE; LIPID; PLASMID DNA; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FISHER EXACT TEST; GENE INSERTION; GUINEA PIG; IMMUNIZATION; IMMUNOGENICITY; MALE; MOLECULAR CLONING; MORTALITY; NEWBORN; NONHUMAN; PLASMID; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; THIRD TRIMESTER PREGNANCY; TRANSPOSON; VACCINATION; VIRUS GENOME; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS VACCINES; DISEASE TRANSMISSION, VERTICAL; DNA TRANSPOSABLE ELEMENTS; ESCHERICHIA COLI; FEMALE; GENOME, VIRAL; GUINEA PIGS; MICE; MOLECULAR SEQUENCE DATA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ROSEOLOVIRUS; VACCINES, DNA; VIRAL LOAD;

EID: 33747374887     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.077     Document Type: Article

References (31)

1. Demmler G.J. Congenital cytomegaloviral infection and disease. Semin Pediatr Infect Dis 10 (1999) 195-200
2. Bale J.F., Miner L., and Petheram S.J. Congenital cytomegalovirus infection. Curr Treat Options Neurol 4 (2002) 225-230
3. In: Stratton K.R., Durch J.S., and Lawrence RS (Eds). Vaccines for the 21st century: a tool for decision making (1999), Committee to Study Priorities for Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine, Washington, DC
4. Schleiss M.R., and Heineman T.C. Progress toward an elusive goal: current status of cytomegalovirus vaccines. Expert Rev Vaccines 4 (2005) 381-406
5. Bia F.J., Griffith B.P., Fong C.K., and Hsiung G.D. Cytomegaloviral infections in the guinea pig: experimental models for human disease. Rev Infect Dis 5 (1983) 177-195
6. Tsutsui Y., Kosugi I., and Kawasaki H. Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models. Rev Med Virol 15 (2005) 327-345
7. Schleiss M.R. Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns. ILAR J 47 (2006) 65-72
8. Griffith B.P., McCormick S.R., Fong C.K.Y., et al. The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol 55 (1985) 402-409
9. Schleiss M.R., Bourne N., and Bernstein D.I. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. J Infect Dis 188 (2003) 1868-1874
10. Schleiss M.R., Bourne N., Stroup G., et al. Protection against congenital cytomegalovirus (CMV) infection and disease in guinea pigs conferred by a purified recombinant glycoprotein B (gB) vaccine. J Infect Dis 189 (2004) 1374-1381
11. McGregor A., and Schleiss M.R. Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli. Mol Gen Metab 72 (2001) 15-26
12. Brune W., Menard C., Hobom U., et al. Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis. Nat Biotechnol 17 (1999) 360-364
13. McGregor A., Liu F., and Schleiss M.R. Rapid identification of essential and non-essential genes encoded on the guinea pig cytomegalovirus (GPCMV) genome via transposome mutagenesis of an infectious BAC clone. Virus Res 101 (2004) 101-108
14. McGregor A., Liu F., and Schleiss M.R. Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83). J Virol 78 (2004) 9872-9889
15. Schleiss M.R., Bourne N., Jensen N.J., et al. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83. Viral Immunol 13 (2000) 155-167
16. Schleiss M.R., and Lacayo J. The guinea pig model of congenital cytomegalovirus infection. In: Reddehase M.J. (Ed). Cytomegaloviruses: pathogenesis, molecular biology and infection control (2005), Horizon Scientific Press Ltd., Wymondham, Norfolk, UK [Chapter 25]
17. Schleiss M.R., McGregor A., Jensen N.J., et al. Molecular characterization of the guinea pig cytomegalovirus UL83 (pp65) protein homolog. Virus Genes 19 (1999) 205-221
18. Bradshaw P.A., Duran-Guarino M.R., Perkins S., et al. Localization of antigenic sites on human cytomegalovirus virion structural proteins encoded by UL48 and UL56. Virology 205 1 (1994) 321-328
19. Ogawa-Goto K., Irie S., Omori A., et al. An endoplasmic reticulum protein, p180, is highly expressed in human cytomegalovirus-permissive cells and interacts with the tegument protein encoded by UL48. J Virol 76 5 (2002) 2350-2362
20. Desai P.J. A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells. J Virol 74 (2000) 11608-11618
21. Suter M., Lew A.M., Grob P., et al. BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc Natl Acad Sci USA 96 (1999) 12697-12702
22. Meseda C.A., Schmeisser F., Pedersen R., et al. DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome. Virology 318 1 (2004) 420-428
23. Petherbridge L., Howes K., Baigent S.J., et al. Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J Virol 77 (2003) 8712-8718
24. Cicin-Sain L., Brune W., Bubic I., et al. Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo. J Virol 77 (2003) 8249-8255
25. Redwood A.J., Messerle M., Harvey N.L., et al. Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. J Virol 79 (2005) 2998-3008
26. Strive T., Hardy C.M., French N., et al. Development of canine herpesvirus based antifertility vaccines for foxes using bacterial artificial chromosomes. Vaccine 24 (2006) 980-988
27. D'Souza S., Rosseels V., Denis O., et al. Improved tuberculosis DNA vaccines by formulation in cationic lipids. Infect Immun 70 (2002) 3681-3688
28. Perrie Y., Frederik P.M., and Gregoriadis G. Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine 19 (2001) 3301-3310
29. Yoshikawa T., Imazu S., Gao J.Q., et al. Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine. Biochem Biophys Res Commun 325 (2004) 500-505
30. Sedegah M., Rogers W.O., Belmonte A., et al. Vaxfectin enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines. Vaccine 10 (2006) 1921-1927
31. Vilalta A., Mahajan R.K., Hartikka J., et al. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration, Part I. Hum Gene Ther 16 (2005) 1143-1150